摘要
成人Still病(AOSD)是一种病因未明的多因素自身炎症性疾病,临床表现复杂,以发热、皮疹、关节炎,痛、淋巴结肿大、白细胞升高等为主要表现。AOSD发病机制尚不明确,目前认为多种炎症细胞及因子参与其发病。AOSD的治疗以激素及免疫抑制剂为主。近年来,随着自身炎症性疾病的研究进展,以及生物制剂的研发上市,人们对AOSD的发病机制和治疗策略有了新的认识。本文针对AOSD的发病机制及治疗新进展予以综述。
Adult-onset Still disease (AOSD) is a polygenic autoinflammatory disease with uncertain etiology. The clinical manifestations are complex, including high-spiking fever, rash, arthritis, arthralgia, lymphadenopathy, and leukocytosis. The pathogenesis of AOSD is still unclear, whereas it has been confirmed that many inflammatory cells and eytokines take part in the development of AOSD. The treatment of AOSD is mainly based on corticosteroids and immunosuppressive agents. Recently, with the research progress of autoinflammatory diseases and the emerging biological agents, we have new knowledge on the pathogenesis and therapeutic strategies of AOSD. This article reviews the current progress in pathogenesis and therapy of AOSD.
作者
赵梦珠
沈敏
Zhao Mengzhu;Shen Min(Department of Rheumatology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College,Key Laboratory of Rheumatology and Clinical Immunology,Ministry of Education,Beijing 100730,China)
出处
《中华全科医师杂志》
2018年第10期830-834,共5页
Chinese Journal of General Practitioners
基金
国家自然科学基金(81501405)
中国医学科学院医学与健康科技创新工程项目(2017-12M-3-001)